Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Lamond Capital Partners LLC (CIK 1542550) reported $14.3M across 1 reported positions in its SEC 13F filing for 2016-03-31. Largest positions: ABBV ($14.3M, 100.00%), AMGN ($0, 0.00%), RXDX1 ($0, 0.00%), IMMU ($0, 0.00%), ORCL ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ABBV | ABBVIE INC | $14.3M | 100.00% | 250,000 | Trimmed |
| 2 | AMGN | AMGEN INC | $0 | 0.00% | 0 | Exited |
| 3 | RXDX1 | IGNYTA INC | $0 | 0.00% | 0 | Exited |
| 4 | IMMU | IMMUNOMEDICS INC | $0 | 0.00% | 0 | Exited |
| 5 | ORCL | ORACLE CORP | $0 | 0.00% | 0 | Exited |
| 6 | PBYI | PUMA BIOTECHNOLOGY INC | $0 | 0.00% | 0 | Exited |
| 7 | ZLTQ | ZELTIQ AESTHETICS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2016-03-31